Humana Statistics
Total Valuation
Humana has a market cap or net worth of $21.23 billion. The enterprise value is $30.30 billion.
Important Dates
The last earnings date was Wednesday, February 11, 2026, before market open.
| Earnings Date | Feb 11, 2026 |
| Ex-Dividend Date | Mar 27, 2026 |
Share Statistics
Humana has 120.60 million shares outstanding. The number of shares has decreased by -0.04% in one year.
| Current Share Class | 120.60M |
| Shares Outstanding | 120.60M |
| Shares Change (YoY) | -0.04% |
| Shares Change (QoQ) | -0.34% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 102.41% |
| Float | 120.30M |
Valuation Ratios
The trailing PE ratio is 17.89 and the forward PE ratio is 18.22. Humana's PEG ratio is 1.30.
| PE Ratio | 17.89 |
| Forward PE | 18.22 |
| PS Ratio | 0.16 |
| Forward PS | 0.14 |
| PB Ratio | 1.20 |
| P/TBV Ratio | 3.10 |
| P/FCF Ratio | 56.62 |
| P/OCF Ratio | 23.05 |
| PEG Ratio | 1.30 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 8.49, with an EV/FCF ratio of 80.81.
| EV / Earnings | 25.51 |
| EV / Sales | 0.23 |
| EV / EBITDA | 8.49 |
| EV / EBIT | 9.24 |
| EV / FCF | 80.81 |
Financial Position
The company has a current ratio of 2.00, with a Debt / Equity ratio of 0.75.
| Current Ratio | 2.00 |
| Quick Ratio | 1.53 |
| Debt / Equity | 0.75 |
| Debt / EBITDA | 3.53 |
| Debt / FCF | 35.39 |
| Interest Coverage | 5.20 |
Financial Efficiency
Return on equity (ROE) is 7.04% and return on invested capital (ROIC) is 8.69%.
| Return on Equity (ROE) | 7.04% |
| Return on Assets (ROA) | 4.30% |
| Return on Invested Capital (ROIC) | 8.69% |
| Return on Capital Employed (ROCE) | 10.08% |
| Weighted Average Cost of Capital (WACC) | 5.63% |
| Revenue Per Employee | $1.93M |
| Profits Per Employee | $17,715 |
| Employee Count | 67,060 |
| Asset Turnover | 2.72 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Humana has paid $250.00 million in taxes.
| Income Tax | 250.00M |
| Effective Tax Rate | 17.21% |
Stock Price Statistics
The stock price has decreased by -30.96% in the last 52 weeks. The beta is 0.44, so Humana's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | -30.96% |
| 50-Day Moving Average | 234.03 |
| 200-Day Moving Average | 250.93 |
| Relative Strength Index (RSI) | 28.96 |
| Average Volume (20 Days) | 2,842,028 |
Short Selling Information
The latest short interest is 5.85 million, so 4.85% of the outstanding shares have been sold short.
| Short Interest | 5.85M |
| Short Previous Month | 5.30M |
| Short % of Shares Out | 4.85% |
| Short % of Float | 4.87% |
| Short Ratio (days to cover) | 2.99 |
Income Statement
In the last 12 months, Humana had revenue of $129.66 billion and earned $1.19 billion in profits. Earnings per share was $9.84.
| Revenue | 129.66B |
| Gross Profit | 18.85B |
| Operating Income | 3.28B |
| Pretax Income | 1.45B |
| Net Income | 1.19B |
| EBITDA | 3.57B |
| EBIT | 3.28B |
| Earnings Per Share (EPS) | $9.84 |
Full Income StatementBalance Sheet
The company has $19.90 billion in cash and $13.27 billion in debt, with a net cash position of -$9.07 billion or -$75.21 per share.
| Cash & Cash Equivalents | 19.90B |
| Total Debt | 13.27B |
| Net Cash | -9.07B |
| Net Cash Per Share | -$75.21 |
| Equity (Book Value) | 17.74B |
| Book Value Per Share | 146.42 |
| Working Capital | 16.39B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $921.00 million and capital expenditures -$546.00 million, giving a free cash flow of $375.00 million.
| Operating Cash Flow | 921.00M |
| Capital Expenditures | -546.00M |
| Free Cash Flow | 375.00M |
| FCF Per Share | $3.11 |
Full Cash Flow StatementMargins
Gross margin is 14.54%, with operating and profit margins of 2.53% and 0.92%.
| Gross Margin | 14.54% |
| Operating Margin | 2.53% |
| Pretax Margin | 1.12% |
| Profit Margin | 0.92% |
| EBITDA Margin | 2.75% |
| EBIT Margin | 2.53% |
| FCF Margin | 0.29% |
Dividends & Yields
This stock pays an annual dividend of $3.54, which amounts to a dividend yield of 2.01%.
| Dividend Per Share | $3.54 |
| Dividend Yield | 2.01% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 35.98% |
| Buyback Yield | 0.04% |
| Shareholder Yield | 2.05% |
| Earnings Yield | 5.60% |
| FCF Yield | 1.77% |
Dividend DetailsAnalyst Forecast
The average price target for Humana is $241.60, which is 37.23% higher than the current price. The consensus rating is "Hold".
| Price Target | $241.60 |
| Price Target Difference | 37.23% |
| Analyst Consensus | Hold |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 9.19% |
| EPS Growth Forecast (5Y) | 31.45% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on August 1, 1991. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Aug 1, 1991 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |
